Emerald Acquisition’s Alder Biopharmaceuticals ALDR Stock Holding History

Emerald Acquisition’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$81K	Buy	+2,470	New	+$75.2K	﹤0.01%	2842

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's ALDR Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Alder Biopharmaceuticals (ALDR) in Q3 2016: 2,470 shares worth $81K. The stake represents ﹤0.01% of the portfolio and ranks #2842 among its holdings.

159 funds tracked by Wall St. Rank hold ALDR as of Q3 2016.

Emerald Acquisition held 2,470 shares of Alder Biopharmaceuticals worth $81K as of Q3 2016.
Alder Biopharmaceuticals was a new Emerald Acquisition position in Q3 2016.
Alder Biopharmaceuticals made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2842 holding.
159 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.